---
title: "Pfizer Ltd (PFIZER) — Share Price, Financials & Analysis"
symbol: "PFIZER"
company: "Pfizer Ltd"
canonical: "https://tapetide.com/stocks/PFIZER"
isin: "INE182A01018"
nse_symbol: "PFIZER"
bse_code: "500680"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 18697.56
generated_at: "2026-09-13T19:10:10.858Z"
---

# Pfizer Ltd (PFIZER)

Canonical page: https://tapetide.com/stocks/PFIZER

## Company

- **NSE Symbol:** PFIZER
- **BSE Code:** 500680
- **ISIN:** INE182A01018
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1999-04-28
- **CEO:** Ms. Meenakshi Nevatia
- **Employees:** 1598
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** pfizerindia.com

## About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1]
It is the 3rd largest multinational pharmaceutical company in India.[2]

## Latest Price

- **Price:** ₹4060.2
- **Change:** -35.2 (-0.86%)
- **Open:** ₹4103.1
- **Day High:** ₹4123.8
- **Day Low:** ₹4054
- **Previous Close:** ₹4095.4
- **Volume:** 138685
- **As Of:** 2026-09-11T10:23:56+00:00

## Key Fundamentals

Observed at 2026-09-11T04:49:36.352983Z.

- **Market Cap:** ₹18697.56 Cr
- **Classification:** Smallcap
- **P/E (reported):** 25.5
- **P/E (TTM):** 25.27
- **EPS (TTM):** ₹160.7
- **EPS (reported):** ₹131.73
- **Book Value:** ₹918.71
- **Price to Book:** 4.46
- **Dividend Yield:** 1.83%
- **ROE:** 17.19%
- **ROCE:** 22.94%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹2707.6 Cr
- **Net Income:** ₹722.4 Cr
- **EBITDA:** ₹1092 Cr
- **52-Week High:** ₹5578.5
- **52-Week Low:** ₹4080
- **RSI (14):** 19.19

## Tapetide Score

- **Score:** 59 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 84.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.69 | 9% |
| growth | 26.66 | 9% |
| momentum | 13.1 | 12% |
| ownership | 45.65 | 24% |
| quality | 72.73 | 22% |
| valuation | 81.9 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 58.3%

### Weaknesses

- The company has delivered a poor sales growth of 2.39% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 46.66% | 276.72% | 45.05% |
| ebitda margin growth | 2.35% | 8.44% | 17.34% | 20.03% |
| net income growth | 2.35% | -5.89% | 8% | 9% |
| revenue growth | 2.8% | 10.35% | 1% | 2% |
| roce | — | -2.8% | 10.93% | 23.59% |
| roe | — | -5.55% | 16.91% | -19.64% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 575 | 540 | 547 | 563 | 589 | 538 | 592 | 603 | 642 | 645 | 629 | 653 |
| Expenses | 393 | 387 | 357 | 385 | 399 | 392 | 364 | 393 | 412 | 417 | 393 | 406 |
| Operating Profit | 183 | 153 | 189 | 177 | 189 | 146 | 228 | 210 | 230 | 228 | 236 | 248 |
| OPM % | 32 | 28 | 35 | 32 | 32 | 27 | 38 | 35 | 36 | 35 | 38 | 38 |
| Other Income | 36 | 44 | 75 | 42 | 43 | 43 | 217 | 67 | 42 | -20 | 50 | 45 |
| Interest | 3 | 3 | 7 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 1 |
| Depreciation | 15 | 18 | 14 | 15 | 15 | 15 | 16 | 14 | 14 | 14 | 15 | 14 |
| Profit before tax | 201 | 176 | 244 | 203 | 215 | 172 | 426 | 260 | 255 | 192 | 269 | 277 |
| Tax % | 26 | 26 | 27 | 26 | 26 | 26 | 22 | 26 | 26 | 26 | 26 | 26 |
| Net Profit | 149 | 130 | 179 | 151 | 158 | 128 | 331 | 192 | 189 | 142 | 200 | 204 |
| EPS in Rs | 32.56 | 28.41 | 39.1 | 32.94 | 34.61 | 27.89 | 72.34 | 41.91 | 41.32 | 31 | 43.68 | 44.7 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1969 | 2082 | 2152 | 2239 | 2611 | 2425 | 2193 | 2281 | 2520 | 2570 |
| Expenses | 1468 | 1516 | 1578 | 1526 | 1775 | 1616 | 1555 | 1540 | 1615 | 1628 |
| Operating Profit | 501 | 566 | 574 | 712 | 836 | 809 | 638 | 742 | 904 | 942 |
| OPM % | 25 | 27 | 27 | 32 | 32 | 33 | 29 | 33 | 36 | 37 |
| Other Income | 114 | 167 | 183 | 81 | 63 | 134 | 185 | 344 | 139 | 116 |
| Interest | 1 | 2 | 11 | 15 | 11 | 13 | 15 | 8 | 10 | 8 |
| Depreciation | 66 | 71 | 103 | 109 | 115 | 106 | 62 | 61 | 58 | 58 |
| Profit before tax | 548 | 660 | 642 | 669 | 773 | 824 | 746 | 1016 | 976 | 993 |
| Tax % | 34 | 35 | 21 | 26 | 21 | 24 | 26 | 24 | 26 | — |
| Net Profit | 360 | 429 | 509 | 498 | 613 | 624 | 551 | 768 | 722 | 735 |
| EPS in Rs | 78.71 | 93.79 | 111.29 | 108.77 | 133.9 | 136.38 | 120.52 | 167.79 | 157.92 | 160.7 |
| Dividend Payout % | 25 | 24 | 297 | 32 | 26 | 29 | 29 | 98 | 48 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves | 2373 | 2637 | 2966 | 3350 | 2347 | 2819 | 3162 | 3550 | 4172 | 4157 |
| Borrowings | 2 | 2 | 2 | 2 | 63 | 39 | 41 | 40 | 108 | 70 |
| Other Liabilities | 840 | 1004 | 926 | 1007 | 810 | 997 | 752 | 593 | 585 | 649 |
| Total Liabilities | 3261 | 3690 | 3940 | 4405 | 3266 | 3901 | 4001 | 4229 | 4911 | 4922 |
| Fixed Assets | 902 | 950 | 886 | 973 | 894 | 869 | 749 | 713 | 724 | 678 |
| CWIP | 15 | 1 | 0 | 1 | 3 | 1 | 8 | 0 | 8 | 20 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2343 | 2739 | 3054 | 3432 | 2369 | 3030 | 3244 | 3516 | 4180 | 4224 |
| Total Assets | 3261 | 3690 | 3940 | 4405 | 3266 | 3901 | 4001 | 4229 | 4911 | 4922 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 329 | 332 | 98 | 323 | 427 | 667 | 356 | 257 | 660 | 968 |
| Cash from Investing Activity | -250 | -238 | 35 | 1530 | -469 | -575 | -36 | 54 | -71 | -562 |
| Cash from Financing Activity | -83 | -110 | -110 | -164 | -1571 | -181 | -346 | -235 | -205 | -798 |
| Net Cash Flow | -3 | -17 | 23 | 1690 | -1613 | -88 | -26 | 75 | 383 | -392 |
| Free Cash Flow | 394 | 262 | 125 | 343 | 410 | 654 | 292 | 291 | 783 | 944 |
| CFO/OP | 146 | 105 | 59 | 93 | 89 | 107 | 81 | 64 | 110 | 105 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 20 | 29 | 30 | 29 | 18 | 20 | 23 | 31 | 31 | 26 |
| Inventory Days | 148 | 147 | 189 | 198 | 199 | 173 | 175 | 200 | 214 | 195 |
| Days Payable | 178 | 245 | 213 | 197 | 130 | 102 | 91 | 77 | 68 | 89 |
| Cash Conversion Cycle | -10 | -69 | 6 | 31 | 87 | 91 | 107 | 154 | 177 | 132 |
| Working Capital Days | -47 | -57 | -16 | -8 | 3 | -14 | 1 | 24 | 23 | 9 |
| ROCE % | 17 | 21 | 23 | 20 | 23 | 29 | 26 | 22 | 21 | 24 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
| FIIs | 2.82% | 3.03% | 3.33% | 3.22% | 3.54% | 2.75% | 2.18% | 2.39% | 2.6% | 2.71% | 2.81% | 1.65% |
| DIIs | 15.01% | 15.15% | 15.33% | 15.84% | 16.03% | 16.79% | 17.1% | 17.23% | 17.1% | 17.05% | 16.89% | 17.8% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 13.61% | 13.21% | 12.9% | 12.55% | 12.15% | 12.12% | 12.34% | 12.02% | 12.08% | 11.93% | 11.87% | 12.04% |
| Others | 4.64% | 4.69% | 4.52% | 4.46% | 4.35% | 4.41% | 4.45% | 4.43% | 4.29% | 4.39% | 4.51% | 4.59% |
| No. of Shareholders | 116948 | 112456 | 109214 | 106098 | 98824 | 105015 | 108261 | 103222 | 103480 | 100933 | 99545 | 102478 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 6 / 1 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 4446.51 | Sell |
| EMA (10) | 4383.4 | Sell |
| SMA (20) | 4639.87 | Sell |
| EMA (20) | 4542.46 | Sell |
| SMA (50) | 4702.74 | Sell |
| EMA (50) | 4649.55 | Sell |
| SMA (100) | 4662.45 | Sell |
| EMA (100) | 4689.98 | Sell |
| SMA (200) | 4766.99 | Sell |
| EMA (200) | 4742.8 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 18.45 | Buy |
| MACD (12,26,9) | -158.89 | Sell |
| Stochastic (14,3,3) | 1.28 | Buy |
| ADX (14) | 26.91 | Buy |
| Williams %R (14) | -99.25 | Buy |
| ATR (14) | 111.57 | Neutral |
| ROC (12) | -15.46 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 21.38 | Buy |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 4 | 80% |
| Hold | 1 | 20% |
| Sell | 0 | 0% |

Based on 5 analyst ratings, observed at 2026-09-11T04:49:34.226486+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Board Meeting Outcome for Discontinuation Of Minipress XL.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6db5fe7d-32fb-4a1d-b50c-30cacd93af1c.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9051fb77-3fda-42a6-959f-e11dab40d899.pdf) |
| 2026-07-29 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e55e4de-53e3-4929-aa27-ad8f1d599317.pdf) |
| 2026-07-28 | [Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd8c05c4-b5d5-406b-b39f-2661febc0f05.pdf) |
| 2026-07-28 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2068b4be-eb57-4213-92e1-f53e5e2babb7.pdf) |
| 2026-07-27 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=490fb24b-3801-4b77-bead-23429d0a5b07.pdf) |
| 2026-07-20 | [Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a58b4b5-f316-4494-9c3a-4f674f1270a9.pdf) |
| 2026-07-17 | [Response To Clarification Sought By BSE Limited.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64d64cab-724e-4c25-adf6-eba3b11e5423.pdf) |
| 2026-07-10 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b3fb1eb-1848-49b6-ab29-94481bf2b79e.pdf) |
| 2026-07-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7b20eac-b9a7-4ee6-93c7-3f02a1ff3616.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jan - Certificate confirming compliance with Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the quarter ended December, 31, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan - Certificate confirming compliance with Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the quarter ended December, 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5d6dfede-42ee-45d1-b306-c2ff5a0da23c.pdf) |
| 9 Feb - Q3/9M Dec 31, 2025 results: Q net profit ₹141.84cr; exceptional charge ₹58.20cr; exclusive marketing deal with Cipla. | [Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. 9 Feb - Q3/9M Dec 31, 2025 results: Q net profit ₹141.84cr; exceptional charge ₹58.20cr; exclusive marketing deal with Cipla.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4cae829d-ec9a-483c-8be3-10978466e2e1.pdf) |
| 9 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6a2af89-1974-4e1d-9d78-bc306af07d4e.pdf) |
| 8 Apr - Newspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Apr - Newspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/67e1f132-0dcb-4e66-b6f8-5e319d789c5b.pdf) |
| 5 May - Board meets May 12, 2026 to approve Q4 and FY26 results, and consider dividend. | [Board Meeting Intimation for Board Meeting To Consider And Approve The Financial Results For The Quarter And Year Ended March 31, 2026. 5 May - Board meets May 12, 2026 to approve Q4 and FY26 results, and consider dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f2cc8c66-57e2-4f1a-9e6b-656d64d38d51.pdf) |
| 5 Feb - SEBI special window Feb 5, 2026–Feb 4, 2027 for re-lodgement and dematerialisation of pre-April 1, 2019 physical share transfers. | [Newspaper Advertisement 5 Feb - SEBI special window Feb 5, 2026–Feb 4, 2027 for re-lodgement and dematerialisation of pre-April 1, 2019 physical share transfers.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16014756-1ddb-45a7-b8ef-e04b6ef2c7fb.pdf) |
| 31 Mar - Deepak Rakheja resigns effective 8 July 2026; Anil Pattanshetty exits March 31, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 31 Mar - Deepak Rakheja resigns effective 8 July 2026; Anil Pattanshetty exits March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9366a844-1355-479f-b142-0ba06c406fef.pdf) |
| 30 Jan - Board meeting Feb 9, 2026 to approve quarter and nine-month results ended Dec 31, 2025; trading window closed. | [Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. 30 Jan - Board meeting Feb 9, 2026 to approve quarter and nine-month results ended Dec 31, 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ddcbd3ff-73c5-46de-8714-4a0ad709518b.pdf) |
| 28 Mar - Trading window closed from Mar 31, 2026 (COB) until 48 hours after results public. | [Closure of Trading Window 28 Mar - Trading window closed from Mar 31, 2026 (COB) until 48 hours after results public.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b9e14e7b-9272-4ce1-ae41-dccec386976b.pdf) |
| 24 Apr - Pfizer received FY23 income-tax demand of Rs 85.74 crore and penalty show-cause notice on April 23, 2026. | [Intimation Pursuant To Regulation 30 Of SEBI LODR Regulations, 2015 24 Apr - Pfizer received FY23 income-tax demand of Rs 85.74 crore and penalty show-cause notice on April 23, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/923708ed-8de5-48cf-bec1-fd6839d0a1e1.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-12 | [Audited Financial Results For The Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31f2203d-eccd-4f47-927a-3daef7af345a.pdf) |
| 2025-08-13 | [Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2025 Held Today August 13 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f866d67-cbc6-4d5e-8a13-caf26cc7468e.pdf) |
| 2024-02-09 | [Unaudited Financial Results For The Quarter Ended December 31, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98d24415-4ba4-46c2-a57c-28a5e4a59cc1.pdf) |
| 2023-10-28 | [Pfizer Limited - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a32a3ff-53f4-4eff-bcdc-65f62fa9e6ce.pdf) |
| 2023-10-28 | [Board Meeting Outcome for Pfizer Limited Unaudited Financial Results - September 30 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da6c0040-80fb-4e8e-845d-c52d447245f9.pdf) |
| 2023-08-11 | [Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccd85299-f797-412f-bc21-49b7fc33eb37.pdf) |
| 2023-08-11 | [Board Meeting Outcome for Pfizer Limited Unaudited Financial Results - Quarter Ended June 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9272725c-fff2-4c37-a32f-ff5252b41c28.pdf) |
| 2023-05-15 | [Board Meeting Outcome for Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2023 - Outcome Of Board Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06758cd0-a967-4018-8338-9a4fab2a2581.pdf) |
| 2023-02-09 | [Board Meeting Outcome for Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=327ed073-ae66-4e81-a144-b60eeca54035.pdf) |
| 2023-02-09 | [Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c26de54-f443-424b-9453-37d2638e9041.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1016_PFIZER_2012_2013_16082013113811.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ff1835d-837a-4ff3-b857-2a61e2130207.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca2d461a-9579-4603-b773-388de30d5565.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f95397ef-bd6f-4b5c-8ed6-151421762f49.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a636b83a-573c-48cc-a7bf-d9dfa9c34f5c.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500680/74114500680.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500680/69146500680.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500680/5006800320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500680/5006800319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500680/5006800318.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2016 | [Concall - Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228C08F1_8F65_458D_B6E8_80D9399961B7_165726.pdf) |
| May 2017 | [Concall - May 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a306898-c4e3-4f7e-aece-61e65a5e4733.pdf) |
| May 2017 | [Concall - May 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/5/3a306898-c4e3-4f7e-aece-61e65a5e4733.pdf) |
| May 2016 | [Concall - May 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04282890_0507_464D_B12B_6B23A878262F_163149.pdf) |
| Feb 2017 | [Concall - Feb 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45EBD7D9_1846_47C4_9BD8_7CD66CDED8CB_165427.pdf) |
| Feb 2016 | [Concall - Feb 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6107176F_B6F2_4C62_BAAF_22C1DB73717F_161003.pdf) |
| Aug 2020 | [Concall - Aug 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db5745d1-8eac-4e5c-8daf-e12a267909b7.pdf) |
| Aug 2020 | [Concall - Aug 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db5745d1-8eac-4e5c-8daf-e12a267909b7.pdf) |
| Aug 2016 | [Concall - Aug 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8198EA0B_9F13_4212_A5C3_68A867E42B33_165813.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:10.858Z.